Patent details

EP3076969 Title: DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR

Basic Information

Publication number:
EP3076969
PCT Application Number:
IB2014066558
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP148126584
PCT Publication Number:
WO2015083101
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
French Title of Invention:
SCHÉMA POSOLOGIQUE D'UN INHIBITEUR DE LA PHOSPHATIDYLINOSITOL 3-KINASE SÉLECTIF DE L'ISOFORME ALPHA
German Title of Invention:
DOSIERUNGSSCHEMA FÜR EINEN ALPHA-ISOFORM-SELEKTIVEN PHOSPHATIDYLINOSITOL-3-KINASE-HEMMER
SPC Number:

Dates

Filing date:
03/12/2014
Grant date:
01/09/2021
EP Publication Date:
12/10/2016
PCT Publication Date:
11/06/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/09/2021
EP B1 Publication Date:
01/09/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/12/2021
Expiration date:
03/12/2034
Renunciation date:
Revocation date:
14/10/2022
Annulment date:

Owner

From:
25/08/2021
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
DI TOMASO, Emmanuelle
Address:
United States (US)

2

Name:
MASSACESI, Cristian
Address:
France (FR)

3

Name:
TAVORATH, Ranjana
Address:
United States (US)

4

Name:
FRITSCH, Christine
Address:
Switzerland (CH)

5

Name:
SCHNELL, Christian Rene
Address:
Switzerland (CH)

6

Name:
GERMA, Marie-Caroline
Address:
France (FR)

Priority

Priority Number:
13306679
Priority Date:
06/12/2013
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/4439; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202135
Publication date:
01/09/2021
Description:
Grant (B1)

2

Issue number:
202140
Publication date:
06/10/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202227
Publication date:
06/07/2022
Description:
Opposition procedure started

4

Issue number:
202308
Publication date:
22/02/2023
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages